Patients with atrial fibrillation are at higher risk of suffering stroke and other complications related to the development of blood clots in their heart. Until 2010, the only oral anticoagulant (blood thinner) to prevent strokes in Afib was warfarin (Coumadin®). Now there are two new oral anticoagulants available in the United States--dabigatran (Pradaxa®) and rivaroxaban …
Read More
In December of 2012, the American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts will be sponsoring three Living with Atrial Fibrillation programs in Dallas, Houston, and Tampa. Learn more at: American College of Cardiology’s (ACC) CardioSmart initiative and Mended Hearts are sponsoring Living with Atrial Fibrillation programs
Read More
The Alliance for Aging Research and the AFib Optimal Treatment Task Force have released a new survey that found that atrial fibrillation patients are active in the decision-making process regarding their treatment. Learn more and access the survey reports at: Alliance for Aging Research Releases Survey of AFib Patients 65+ that Finds Active Participation in …
Read More
Recently, StopAfib.org partnered with the Cleveland Clinic to give you an opportunity to ask questions of three of their atrial fibrillation experts, Dr. Walid Saliba, Dr. Sergio Pinski, and Dr. David Van Wagoner, along with StopAfib.org founder Mellanie True Hills. The transcript of our afib community chat with these atrial fibrillation experts from the Cleveland …
Read More